secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2025-09-18T23:59:59+00:00
Accession:  0001493152-25-013968
Event type: regulatory
Sentiment:  negative
Materiality: 1.00
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Nasdaq to delist ZyVersa Therapeutics common stock effective ~Sep 28, 2025
--------------------------------------------------------------------------

- Nasdaq notified ZyVersa on Sept 14, 2025, of delisting; Form 25 to be filed on or about Sept 18, 2025.
- Stock was suspended from Nasdaq on July 17, 2025; trading on OTCQB since July 28, 2025 under symbol ZVSA.
- Delisting effective ten days after Form 25 filing; company cites failure to meet minimum bid price rule.
- Company's common stock will continue trading on OTCQB without disruption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000149315225013968/0001493152-25-013968-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000149315225013968/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013968

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer